CC The Chemours Company
The Chemours Company (CC) Insider Activity
What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.
Where they traded
Last open-market purchase: August 12, 2026 , by Familiar Calderon Gerardo .
Recent open-market activity
| Date | Insider | Role | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|---|
| Familiar Calderon Gerardo | See Remarks | Buy | 1,935 | $15.53 | $30.1K | 58,547 | |
| Dignam Denise | Chief Executive Officer | Buy | 3,378 | $14.95 | $50.5K | 339,916 | |
| Cowan Alister | Director | Buy | 13,000 | $15.62 | $203.1K | 56,988 | |
| CRANSTON MARY B | Director | Buy | 6,000 | $15.82 | $95.0K | 113,141 | |
| Martinko Joseph T. | See Remarks | Buy | 1,940 | $15.47 | $30.0K | 55,431 | |
| Foley Michael Robert | See Remarks | Buy | 1,934 | $15.51 | $30.0K | — | |
| HOSTETTER SHANE | Chief Financial Officer | Buy | 3,350 | $14.94 | $50.0K | 102,698 |
Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.